Home › Companies › Harmony Biosciences Holdings, Inc. › 2025-2026

Harmony Biosciences Holdings, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Harmony Biosciences Holdings, Inc.’s Form 8-K, filed 2026-05-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
344Asset managers
2,467Fund votes
2026-05-14Meeting date

Proxy season: 2024-2025 2025-2026

Explore Harmony Biosciences Holdings, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Harmony Biosciences Holdings, Inc.

These tallies are Harmony Biosciences Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Harmony Biosciences Holdings, Inc. — official shareholder meeting results, meeting held 2026-05-14
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Geno Germano	44,963,163	--	--	1,524,142	3,894,004	Majority: yes
Elect Director: Troy Ignelzi	32,813,495	--	--	13,673,810	3,894,004	Majority: yes
Elect Director: Ron Philip	31,826,838	--	--	14,660,467	3,894,004	Majority: yes
Elect Director: Andreas Wicki, Ph.D.	25,114,526	--	--	21,372,779	3,894,004	Majority: yes

Source: Harmony Biosciences Holdings, Inc., Form 8-K, filed with the SEC on 2026-05-14 — read the filing on EDGAR.

How asset managers voted at the Harmony Biosciences Holdings, Inc. 2025-2026 meeting

Each item below shows how the 344 asset managers that disclosed a Harmony Biosciences Holdings, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Harmony Biosciences Holdings, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensation disclosure rules.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

65% fund support · no official result

FOR 65%AGAINST 35%

The 335 asset managers below cast 65% of the shares they voted on this item FOR (26,492,749 for, 14,369,376 against).

FOR: 26,492,749 (64.6%)AGAINST: 14,369,376 (35.0%)ABSTAIN: 133,981 (0.3%)NOT VOTED: 1,841 (0.0%)

Largest asset managers voting on “Non-binding, advisory vote on the compensation of our named executive officers pursuant to the SEC's compensat” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Against	Vote
Fidelity	5,859,332	1,495	For
BlackRock	5,574,870	7,425	For
Vanguard	5,006,744	1,657	For
American Century	0	4,044,021	Against
State Street	1,474,254	18,402	For
GEODE CAPITAL MANAGEMENT, LLC	1,309,948	0	For
LSV ASSET MANAGEMENT	1,168,787	5,000	For
Boston Partners	1,133	970,236	Against
Dimensional	0	893,553	Against
Charles Schwab	0	791,592	Against
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	0	617,263	Against
Invesco	0	549,039	Against
Victory Capital	0	479,234	Against
Federated Hermes	449,485	0	For
Northern Trust	390,973	21,933	For
Royce	0	347,805	Against
Renaissance	0	335,329	Against
Allspring	0	335,243	Against
AQR	0	309,936	Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	273,544	0	For
MFS	266,264	0	For
Pacer Funds Trust	262,844	0	For
PRINCIPAL GLOBAL INVESTORS	0	260,171	Against
MELLON INVESTMENTS Corp	246,913	0	For
SEI	242,847	0	For

Showing the 25 largest of 335 asset managers. See all 335 in the interactive database.

2. The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Andreas Wicki, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

54.0% Majority: yes · of votes cast

FOR 54.0%WITHHELD 46.0%

FOR: 25,114,526WITHHELD: 21,372,779

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Andreas Wicki, Ph.D.”): 25,114,526 for, 21,372,779 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 57,867,389 outstanding shares: 43% for, 37% withheld (80% of the company cast a for/withheld vote).

The 98 asset managers below cast 100% of the shares they voted on this item FOR (9,583,801 for, 0 against).

FOR 48.3%ABSTAIN 51.7%

FOR: 9,583,801 (48.3%)ABSTAIN: 10,266,725 (51.7%)

Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	4,653,305	68	For
BlackRock	0	3,594,255	Abstain
Fidelity	2,756,180	43,407	For
American Century	0	1,977,227	Abstain
State Street	1,376	678,001	Abstain
Dimensional	0	660,050	Abstain
Invesco	0	515,987	Abstain
Charles Schwab	380,638	0	For
Royce	0	341,516	Abstain
MFS	0	266,264	Abstain
Pacer Funds Trust	262,844	0	For
Bridge Builder Trust	220,500	8,400	For
ADVISORS' INNER CIRCLE FUND	218,844	0	For
Federated Hermes	179,087	0	For
Victory Capital	0	174,136	Abstain
Allspring	0	167,227	Abstain
RBB FUND, INC.	0	160,775	Abstain
Goldman Sachs	125,471	20,299	For
World Funds Trust	127,823	0	For
SEI	119,950	0	For
Prudential/PGIM	48,229	71,179	Abstain
First Trust	0	103,392	Abstain
Equitable	0	102,014	Abstain
OPTIMUM FUND TRUST	87,900	0	For
EA Series Trust	87,202	0	For

Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.

3. The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Geno J. Germano

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 44,963,163WITHHELD: 1,524,142

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Geno Germano”): 44,963,163 for, 1,524,142 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 57,867,389 outstanding shares: 78% for, 3% withheld (80% of the company cast a for/withheld vote).

The 98 asset managers below cast 100% of the shares they voted on this item FOR (19,586,245 for, 0 against).

FOR 99%

FOR: 19,586,245 (98.7%)ABSTAIN: 264,282 (1.3%)

Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	4,653,368	6	For
BlackRock	3,594,255	0	For
Fidelity	2,799,587	0	For
American Century	1,977,227	0	For
State Street	679,377	0	For
Dimensional	660,050	0	For
Invesco	515,987	0	For
Charles Schwab	380,638	0	For
Royce	341,516	0	For
MFS	266,264	0	For
Pacer Funds Trust	262,844	0	For
Bridge Builder Trust	228,900	0	For
ADVISORS' INNER CIRCLE FUND	218,844	0	For
Federated Hermes	179,087	0	For
Victory Capital	174,136	0	For
Allspring	167,227	0	For
RBB FUND, INC.	0	160,775	Abstain
Goldman Sachs	125,471	20,299	For
World Funds Trust	127,823	0	For
SEI	119,950	0	For
Prudential/PGIM	55,790	63,618	Abstain
First Trust	103,392	0	For
Equitable	102,014	0	For
OPTIMUM FUND TRUST	87,900	0	For
EA Series Trust	87,202	0	For

Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.

4. The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Ron Philip

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD 32%

FOR: 31,826,838WITHHELD: 14,660,467

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Ron Philip”): 31,826,838 for, 14,660,467 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 57,867,389 outstanding shares: 55.0% for, 25% withheld (80% of the company cast a for/withheld vote).

The 98 asset managers below cast 100% of the shares they voted on this item FOR (14,171,218 for, 0 against).

FOR 71%ABSTAIN 29%

FOR: 14,171,218 (71.4%)ABSTAIN: 5,679,308 (28.6%)

Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	4,647,569	5,804	For
BlackRock	3,594,255	0	For
Fidelity	2,798,092	1,495	For
American Century	0	1,977,227	Abstain
State Street	678,600	777	For
Dimensional	0	660,050	Abstain
Invesco	515,987	0	For
Charles Schwab	380,638	0	For
Royce	0	341,516	Abstain
MFS	0	266,264	Abstain
Pacer Funds Trust	262,844	0	For
Bridge Builder Trust	82,300	146,600	Abstain
ADVISORS' INNER CIRCLE FUND	0	218,844	Abstain
Federated Hermes	179,087	0	For
Victory Capital	0	174,136	Abstain
Allspring	0	167,227	Abstain
RBB FUND, INC.	0	160,775	Abstain
Goldman Sachs	125,471	20,299	For
World Funds Trust	127,823	0	For
SEI	0	119,950	Abstain
Prudential/PGIM	48,229	71,179	Abstain
First Trust	0	103,392	Abstain
Equitable	63,594	38,420	For
OPTIMUM FUND TRUST	0	87,900	Abstain
EA Series Trust	87,202	0	For

Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.

5. The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until their successors are duly elected and qualified. Troy Ignelzi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%WITHHELD 29%

FOR: 32,813,495WITHHELD: 13,673,810

Harmony Biosciences Holdings, Inc.’s own tally for this item (“Elect Director: Troy Ignelzi”): 32,813,495 for, 13,673,810 withheld, per its Form 8-K filed 2026-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 57,867,389 outstanding shares: 57% for, 24% withheld (80% of the company cast a for/withheld vote).

The 98 asset managers below cast 100% of the shares they voted on this item FOR (11,882,302 for, 0 against).

FOR 60%ABSTAIN 40%

FOR: 11,882,302 (59.9%)ABSTAIN: 7,968,223 (40.1%)

Largest asset managers voting on “The election of four Class III directors to serve until our 2029 annual meeting of stockholders and until thei” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	1,948,727	2,704,645	Abstain
BlackRock	220,599	3,373,656	Abstain
Fidelity	2,780,484	19,103	For
American Century	1,977,227	0	For
State Street	679,377	0	For
Dimensional	660,050	0	For
Invesco	515,987	0	For
Charles Schwab	0	380,638	Abstain
Royce	341,516	0	For
MFS	0	266,264	Abstain
Pacer Funds Trust	262,844	0	For
Bridge Builder Trust	73,900	155,000	Abstain
ADVISORS' INNER CIRCLE FUND	0	218,844	Abstain
Federated Hermes	179,087	0	For
Victory Capital	174,136	0	For
Allspring	167,227	0	For
RBB FUND, INC.	0	160,775	Abstain
Goldman Sachs	125,471	20,299	For
World Funds Trust	127,823	0	For
SEI	0	119,950	Abstain
Prudential/PGIM	7,561	111,847	Abstain
First Trust	103,392	0	For
Equitable	38,420	63,594	Abstain
OPTIMUM FUND TRUST	0	87,900	Abstain
EA Series Trust	87,202	0	For

Showing the 25 largest of 98 asset managers. See all 98 in the interactive database.

6. Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.

DIRECTOR ELECTIONS

99.8% fund support · no official result

FOR 99.7%

The 97 asset managers below cast 99.8% of the shares they voted on this item FOR (19,870,439 for, 28,443 against).

FOR: 19,870,439 (99.8%)AGAINST: 28,443 (0.1%)ABSTAIN: 19,584 (0.1%)

Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm ” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	4,653,371	2	For
BlackRock	3,594,255	0	For
Fidelity	2,799,587	0	For
American Century	1,977,227	0	For
State Street	679,054	323	For
Dimensional	660,050	0	For
Invesco	515,987	0	For
Charles Schwab	380,638	0	For
Royce	341,516	0	For
MFS	266,264	0	For
Pacer Funds Trust	262,844	0	For
Bridge Builder Trust	228,900	0	For
ADVISORS' INNER CIRCLE FUND	218,844	0	For
Federated Hermes	179,087	0	For
Victory Capital	174,136	0	For
Allspring	167,227	0	For
RBB FUND, INC.	160,775	0	For
Goldman Sachs	145,770	0	For
World Funds Trust	127,823	0	For
HUSSMAN INVESTMENT TRUST	120,000	0	For
SEI	119,950	0	For
Prudential/PGIM	119,408	0	For
First Trust	103,392	0	For
Equitable	102,014	0	For
OPTIMUM FUND TRUST	87,900	0	For

Showing the 25 largest of 97 asset managers. See all 97 in the interactive database.

7. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

14% fund support · no official result

9%AGAINST 59%ABSTAIN 32%

The 6 asset managers below cast 14% of the shares they voted on this item FOR (8,522 for, 54,165 against).

FOR: 8,522 (9.2%)AGAINST: 54,165 (58.6%)ABSTAIN: 29,705 (32.2%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
ALGERT GLOBAL LLC	0	0	29,705	Abstain
Empower	0	29,122	0	Against
CLEARWATER INVESTMENT TRUST	0	22,938	0	Against
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	8,522	0	0	For
GLOBEFLEX CAPITAL L P	0	2,083	0	Against
MILLER HOWARD INVESTMENTS INC /NY	0	22	0	Against

8. Ratify Deloitte & Touche LLP as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (52,060 for, 0 against).

FOR: 52,060 (100.0%)

Largest asset managers voting on “Ratify Deloitte & Touche LLP as Auditors” at Harmony Biosciences Holdings, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	29,122	0	0	0	For
CLEARWATER INVESTMENT TRUST	22,938	0	0	0	For

Largest Harmony Biosciences Holdings, Inc. shareholders voting in 2025-2026

Ranked by the number of Harmony Biosciences Holdings, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 57,867,389 shares outstanding at the time of that meeting.

Top Harmony Biosciences Holdings, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	10.13%
2	BlackRock	9.65%
3	Vanguard	8.65%
4	American Century	6.99%
5	State Street	2.58%
6	GEODE CAPITAL MANAGEMENT, LLC	2.26%
7	LSV ASSET MANAGEMENT	2.03%
8	Boston Partners	1.68%
9	Dimensional	1.54%
10	Charles Schwab	1.37%

Reported Harmony Biosciences Holdings, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Harmony Biosciences Holdings, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	12.22%	13F
Marshman Fund Trust II	10.46%	DEF14A
Entities affiliated with BlackRock, Inc.	9.97%	DEF14A
Vanguard Group	8.32%	13F
FMR (Fidelity)	5.46%	13F
Entities affiliated with FMR LLC (Fidelity)	5.38%	DEF14A
Jeffrey S. Aronin	3.78%	DEF14A
Andreas Wicki, Ph.D.	3.71%	DEF14A
Dimensional Fund Advisors	3.59%	13F
State Street	3.08%	13F

Percentages above are of 57,867,389 shares outstanding, as reported by Harmony Biosciences Holdings, Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Harmony Biosciences Holdings, Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Harmony Biosciences Holdings, Inc.'s shareholder meeting held 2026-05-14, in the 2025-2026 proxy season, 344 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,467 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Harmony Biosciences Holdings, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Non-binding, advisory vote on the compensation of our named executive officers pursuant to the… — the reporting funds cast 65% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Harmony Biosciences Holdings, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).